Mike Doustdar Novo Nordisk Novo Novo CEO
Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”
Fraiser Kansteiner Jun 11, 2026 7:00am
Tavneos

Amgen to file 3rd-party review of Tavneos data for FDA hearing

Jun 12, 2026 11:12am
Jazz

Zepzelca saga takes another turn with ph. 3 lung cancer flop

Jun 12, 2026 10:48am
Food and Drug Administration

Regulatory tracker: Novo's oral GLP-1 picks up UK approval

Jun 12, 2026 9:50am
Asia

Astellas, Takeda, RA Capital—Fierce Pharma Asia

Jun 12, 2026 8:23am
Astellas

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm
More News
Fierce Biotech

3 Genentech VPs among those dismissed in latest layoff round

Jun 11, 2026 2:30pm
Fierce Healthcare

HHS ramps up AI use cases, with most in pre-deployment: BPC

Jun 11, 2026 2:00pm

Novo reports data breach, urges patients to 'remain vigilant'

Jun 11, 2026 1:18pm

5 EU countries call for 'unity' in Europe's drug pricing approach

Jun 11, 2026 11:27am